人乳头瘤病毒相关口咽鳞状细胞癌接受三联疗法患者的功能结局
回顾性分析2010年3月至2021年3月单中心255例接受经口机器人手术联合辅助放化疗三联治疗的HPV阳性口咽鳞状细胞癌患者。治疗后1年3.5%患者仍依赖喂养管,平均FOIS评分从术前6.9降至术后首次2.6、治疗结束后5.5。术后3周延迟拔除鼻胃管可预测胃造瘘需求和吞咽语言病理评估中的误吸临床征象。
要点
- 三联治疗后1年仅3.5%患者仍依赖喂养管,长期功能结局较好
- 平均FOIS评分术前6.9,术后首次2.6,治疗结束后5.5
- 术后3周延迟拔除鼻胃管预测胃造瘘需求和误吸征象
核心结论
- HPV相关口咽鳞状细胞癌患者接受三联治疗显示出良好的功能和喂养管结局,长期喂养管依赖率低且FOIS中位数高。
研究设计与样本
- 单机构回顾性病历审查,纳入2010年3月至2021年3月在一家学术医疗中心接受经口机器人手术联合辅助放化疗三联治疗的HPV阳性口咽鳞状细胞癌患者,共255例符合标准,平均年龄61岁,88%为男性。
主要发现
- 术中放置鼻胃管后,31%患者在3周后仍依赖鼻胃管。
- 19%患者放置胃造瘘管,治疗结束后1年总体3.5%患者仍依赖喂养管。
- 平均FOIS评分:术前访视6.9(SD=0.3),术后首次访视2.6(SD=1.8),治疗结束后5.5(SD=1.5)。
- 随访超过2年的亚组(n=118)最近一次访视平均FOIS为6.1(SD=1.3)。
- 吞咽语言病理评估怀疑误吸/渗入临床征象者占18%,经纤维optic内镜吞咽评估和/或钡餐检查确认总体2.7%患者存在误吸征象。
临床怎么用
- 定期吞咽语言病理访视可为该队列提供详细且易于获取的吞咽功能评估手段。
局限性
- 原文为单机构研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe swallowing and feeding-tube outcomes in patients with high-risk oropharyngeal cancer treated with trimodality therapy (TMT), including transoral robotic surgery (TORS) and adjuvant chemoradiotherapy. METHODS: A chart review was conducted on patients with HPV+ OPSCC receiving TMT with TORS at an academic medical center from March 2010 to March 2021. Data collected included demographics, treatment, feeding tube placement, functional oral intake scale (FOIS) scores, and swallowing-language pathology (SLP) evaluations. RESULTS: A total of 255 patients met selection criteria (mean age 61 years, 88% male). Following intraoperative nasogastric tube (NG) placement, 31% remained NG tube dependent after 3 weeks. A gastrostomy tube was placed in 19% of patients, and at 1 year after end-of-treatment (EOT), 3.5% overall remained tube-dependent. Mean FOIS scores were 6.9 (SD = 0.3) at pre-operative visit, 2.6 (1.8) at first post-operative visit, and 5.5 (1.5) after EOT. In the subset of patients with follow-up longer than 2 years (n = 118), the mean FOIS was 6.1 (SD = 1.3) at most recent visit. Clinical signs of aspiration/penetration were suspected on SLP evaluation in 18% of patients. These patients were subsequently evaluated with fiberoptic endoscopic evaluation of swallowing (FEES) and/or barium swallow study, which confirmed signs of aspiration in 2.7% of patients overall. Delayed NG tube removal after 3 weeks was predictive of (1) gastrostomy tube requirement and (2) clinical signs of aspiration on an SLP visit after EOT. CONCLUSIONS: Favorable functional and feeding-tube outcomes are demonstrated in patients with HPV-associated OPSCC undergoing TMT. In this single-institution study, we found low rates of long-term feeding tube dependence and high median FOIS following treatment. Review of routine SLP visits provides a detailed and easily accessible means for assessing swallowing function in this cohort. LEVEL OF EVIDENCE: 4 Laryngoscope, 133:3013-3020, 2023.
引用
- Lu JS, Cao AC, Shimunov D, et al. Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy. Laryngoscope. 2023. PMID: 37129315. doi:10.1002/lary.30714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。